(4-chloro-2-fluoro-phenyl)-[6-methoxy-7-(morpholin-2-ylmethoxy)-quinazolin-4-yl]-amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: (4-chloro-2-fluoro-phenyl)-[6-methoxy-7-(morpholin-2-ylmethoxy)-quinazolin-4-yl]-amine
• 英文别名: N-(4-chloro-2-fluorophenyl)-6-methoxy-7-(morpholin-2-ylmethoxy)quinazolin-4-amine
• 化学式: C₂₀H₂₀ClFN₄O₃
• 分子量: 418.855
• InChiKey: CZJFENQAHHOVJX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  77.5
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  聚合甲醛 、 (4-chloro-2-fluoro-phenyl)-[6-methoxy-7-(morpholin-2-ylmethoxy)-quinazolin-4-yl]-amine 在 甲酸 作用下， 生成 N-(4-chloro-2-fluorophenyl)-7-{[(4-methylmorpholin-2-yl)methyl]oxy}-6-(methyloxy)quinazolin-4-amine
  参考文献：
  名称：

  4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors

  摘要：

  Erythropoietin-producing hepatocellular receptor tyrosine kinase subtype A2 (EphA2) is an attractive therapeutic target for suppressing tumor progression. In our efforts to discover novel small molecules to inhibit EphA2, a class of compound based on 4-substituted quinazoline containing 7-(morpholin-2-ylmethoxy) group was identified as a novel hit by high throughput screening campaign. Structural modification of parent quinazoline scaffolds by introducing substituents on aniline displayed potent inhibitory activities toward EphA2.

  DOI：

  10.1016/j.bmcl.2014.07.081
• 作为产物：
  描述：

  (4-苄基吗啉-2-基)甲醇 在 palladium 10% on activated carbon 、 氢气 、 potassium carbonate 、 三乙胺 、 三氟乙酸 作用下， 以 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 (4-chloro-2-fluoro-phenyl)-[6-methoxy-7-(morpholin-2-ylmethoxy)-quinazolin-4-yl]-amine
  参考文献：
  名称：

  4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors

  摘要：

  Erythropoietin-producing hepatocellular receptor tyrosine kinase subtype A2 (EphA2) is an attractive therapeutic target for suppressing tumor progression. In our efforts to discover novel small molecules to inhibit EphA2, a class of compound based on 4-substituted quinazoline containing 7-(morpholin-2-ylmethoxy) group was identified as a novel hit by high throughput screening campaign. Structural modification of parent quinazoline scaffolds by introducing substituents on aniline displayed potent inhibitory activities toward EphA2.

  DOI：

  10.1016/j.bmcl.2014.07.081

文献信息

• 4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors
  作者：Chae Jo Lim、Kwang-Seok Oh、Jae Du Ha、Jeong Hyun Lee、Ho Won Seo、Chong Hack Chae、Dae-Ghon Kim、Mi-Jin Lee、Byung Ho Lee

  DOI：10.1016/j.bmcl.2014.07.081

  日期：2014.9

  Erythropoietin-producing hepatocellular receptor tyrosine kinase subtype A2 (EphA2) is an attractive therapeutic target for suppressing tumor progression. In our efforts to discover novel small molecules to inhibit EphA2, a class of compound based on 4-substituted quinazoline containing 7-(morpholin-2-ylmethoxy) group was identified as a novel hit by high throughput screening campaign. Structural modification of parent quinazoline scaffolds by introducing substituents on aniline displayed potent inhibitory activities toward EphA2.